{'fraction_non_alphanumeric': 0.04743390357698289, 'fraction_numerical': 0.049766718506998445, 'mean_word_length': 5.3399014778325125, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Fulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome

We report on a 4‐year‐old girl with severe developmental delay, absent speech, and chromosome 22q13.3 deletion (Phelan–McDermid syndrome), karyotype 46,XX.ish del(22)(q13.31qter)(ARSA‐,N85A‐,SHANK3‐). At the age of 3 years, she needed an emergency liver transplantation because of fulminant hepatic failure, most likely caused by hyperacute autoimmune hepatitis triggered by a viral infection. This is the second report of a patient with 22q13.3 deletion and fulminant liver failure. By array‐CGH we identified in this patient a 5.675 Mb terminal deletion (22q13.31 → qter; including ∼55 genes; from NUP50 to RABL2B) and in the previous patient a 1.535 Mb deletion (22q13.32 → qter; including ∼39 genes; from BRD1 to RABL2B). PIM3 is a prime candidate gene for the fulminant hepatic failure in the two patients; SHANK3/PROSAP2 could be another candidate gene. We recommend liver function tests and array‐CGH in the management of patients with Phelan–McDermid syndrome. This patient showed a developmental catch‐up following the liver transplantation, possibly suggesting that chronic hepatic disease could contribute to the developmental delay in a subset of these patients. © 2010 Wiley‐Liss, Inc.